Structurally modified ibogaine analogs exhibit differing affinities for NMDA receptors
- 1 August 1996
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 309 (2) , 159-165
- https://doi.org/10.1016/0014-2999(96)00304-4
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Ibogaine and its congeners are σ2 receptor-selective ligands with moderate affinityEuropean Journal of Pharmacology, 1995
- Inhibitory effects of ibogaine on cocaine self-administration in ratsEuropean Journal of Pharmacology, 1993
- Effects of ibogaine on naloxone‐precipitated withdrawal in morphine‐dependent miceFundamental & Clinical Pharmacology, 1992
- Effects of ibogaine on acute signs of morphine withdrawal in rats: Independence from tremorNeuropharmacology, 1992
- The NMDA receptor antagonist MK-801 prevents long-lasting non-associative morphine tolerance in the ratBrain Research, 1992
- Mechanisms of action of ibogaine and harmaline congeners based on radioligand binding studiesBrain Research, 1992
- Effects and aftereffects of ibogaine on morphine self-administration in ratsEuropean Journal of Pharmacology, 1991
- Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channelsEuropean Journal of Pharmacology, 1989
- Synthesis and absolute configuration of optically pure enantiomers of a ϰ-opioid receptor selective agonistFEBS Letters, 1987
- The Alkaloids of Tabernanthe iboga. Part IV.1 The Structures of Ibogamine, Ibogaine, Tabernanthine and VoacangineJournal of the American Chemical Society, 1958